A higher gene mutation rate was found in non-smoking young Asian female patients with lung adenocarcinoma, especially EGFR mutation, among which mutations in exon E19 and E21 represented the vast majority (87%) of all EGFR mutations in patients with lung cancer (17–21). This evidence concerns the gene EGFR and lung adenocarcinoma.